About Dylan Sammut
Dylan joined Irving Levin in October 2018 as a Research and Editorial Associate and is responsible for reporting on mergers and acquisitions in the healthcare sector. He graduated from Alfred University in May 2014 with a degree in English and Political Science. He currently lives in Bridgeport, CT with his fiancé and his overweight cat, Kimba, and in his free time he plays video games, reads, writes, and hikes on the weekends all year around.
by Dylan Sammut | Sep 23, 2019 9:07 am | Healthcare Market Updates
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online... Read More »
by Dylan Sammut | Sep 16, 2019 11:50 am | eHealth
OptimizeRx (NYSE: OPRX), a digital patient communication company, ramped up its platform last week with the acquisition of RMDY Health for $16 million. RMDY offers a SaaS platform that provides a complete digital framework to help life science and healthcare... Read More »
by Dylan Sammut | Sep 13, 2019 4:15 pm | Healthcare Market Updates
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online... Read More »
by Dylan Sammut | Sep 13, 2019 3:31 pm | Physician Medical Groups
Apollo Medical Holdings, Inc. (OTCQB: AMEH), an integrated population health management company, announced a new acquisition last week. The group acquired Accountable Health Care for $7.25 million, an independent practice association (IPA) that operates a network with... Read More »
by Dylan Sammut | Sep 9, 2019 12:22 pm | Biotechnology, Pharmaceuticals
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) purchased another gene-editing biotech company last week, marking its fourth announced transaction of 2019. The pharmaceutical giant bought Semma Therapeutics for $950 million in an all-cash transaction for all of the... Read More »